With the forthcoming regulatory changes set to come into force over the next couple of years in pharma, management practices will surely be tested. In this article, Tom Nichols, senior director, Pharmacovigilance at Quanticate, details some of the challenges the industry will face.
Outlook
Since the introduction in 2012 of good pharmacovigilance practices (GVPs) in the European Union (EU), the industry has experienced rapid changes and it is showing no sign of slowing. The next two years are looking to be no exception, with 2019 scheduled to be a year that will really test companies’ change management practices.